Morgenthaler Ventures Says, ‘Yes, Mas!’

Juan-Pablo Mas has been appointed a senior associate on the life science team of Morgenthaler Ventures, the California-based VC investor. He will work on life sciences and medical device investments. Prior to joining Morgenthaler, Mas worked with Medtronic and Eli Lilly & Co.


Morgenthaler Ventures Appoints Juan-Pablo Mas as Senior Associate
MENLO PARK, Calif., July 18, 2011 – Morgenthaler Ventures, a leading venture capital firm, today announced the appointment of Juan-Pablo Mas as senior associate on the Life Science Team. Mas will focus on investments in the life science and medical device sectors.
“Morgenthaler Ventures is thrilled to have Juan-Pablo join the Life Science Team,” said Hank Plain, partner, Morgenthaler Ventures. “His experience in developing medical device therapies for cardiovascular disease, structural heart repair, and the neurovasculature will be integral to the firm’s growing investment activity in medical devices.”
Mas is currently a board observer at Innovative Pulmonary Solutions, Miramar Labs, The Foundry, and Cabochon Labs. Prior to joining Morgenthaler Ventures, he worked at Medtronic, Eli Lilly & Co. (in global brand strategy), and at Stanford Hospital (conducting research in the Neurology Department). Mas received an MBA from Stanford Graduate School of Business, an MS in Electrical Engineering from Stanford University, and a BS in Electrical Engineering from The University of Massachusetts, Amherst.

About Morgenthaler Ventures
Morgenthaler Ventures is a premier venture capital firm with $3 billion under management. It has invested in approximately 300 companies in the life science and information technology sectors. Representative life science companies include: Ardian, OncoMed, Catalyst Biosciences, Transcend, Elcelyx, Innovative Pulmonary Solutions, GlobeImmune, Moximed, SetPoint Medical, Kona Medical, FoldRx Pharmaceuticals, and incubators, The Foundry & ForSight Labs.